<DOC>
	<DOCNO>NCT00296361</DOCNO>
	<brief_summary>Primary objective study compare two therapy regimen regard renal function use calculated creatinine clearance . The secondary objective compare efficacy safety profile two therapy regimen .</brief_summary>
	<brief_title>To Compare Efficacy Safety Therapy Tacrolimus With Sirolimus MMF Kidney Transplantation .</brief_title>
	<detailed_description>This phase III study shall provide detailed efficacy safety information compare combination sirolimus tacrolimus current standard tacrolimus combination regimen ( tacrolimus/MMF/steroids ) widely use European centre .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patients 18 60 year age end stage kidney disease undergo primary renal transplantation retransplantation eligible study . Patients receive kidney transplant , cadaveric living donor ( HLA identical ) compatible AB0 blood type include . Patient high immunological risk Cold ischemia time great 30 hour Patient significant liver disease Patient severe hypercholesterolaemia Patient allergic intolerant study medication Patient require ongoing dose corticosteroid . Patient donor know HIV positive Patient malignancy history malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Adult</keyword>
	<keyword>Treatment Outcomes</keyword>
</DOC>